Goldenwell Biotech (GWLL) Non Operating Income (2019 - 2022)

Goldenwell Biotech has reported Non Operating Income for 4 years, with the latest figure at $1.0 in Q2 2022.

• For the quarter ending Q2 2022, Non Operating Income fell 99.62% year-over-year to $1.0; the trailing twelve-month figure through Mar 2023 stood at $1.0 (down 99.96% YoY), and the FY2022 full-year result was $8.0, down 99.38% from the prior year.
• Non Operating Income for Q2 2022 stood at $1.0, down from $7.0 in the prior quarter.
• The five-year high for Non Operating Income was $1272.0 in Q3 2021, with the low at -$12.0 in Q4 2019.
• Historically, Non Operating Income has averaged $334.9 across 4 years, with a median of $18.0 in 2020.
• Annual changes were most pronounced in 2021 — Non Operating Income surged 25340.0% — and 2022, when it sank 99.62%.
• Goldenwell Biotech's Non Operating Income stood at -$12.0 in 2019, then jumped by 141.67% to $5.0 in 2020, then soared by 20460.0% to $1028.0 in 2021, then tumbled by 99.9% to $1.0 in 2022.
• The last three Non Operating Income figures came in at $1.0 (Q2 2022), $7.0 (Q1 2022), and $1028.0 (Q4 2021), per Business Quant data.